Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus acidophilus L-92 and Reduced Allergic Symptoms

Research synthesisLow evidenceModerate effect11 studies · 11 beneficial · 0 neutral · 0 harmful

Across 11 studies, all reported beneficial effects of Lactobacillus acidophilus L-92 for reducing allergic symptoms, with moderate effect sizes observed most frequently. The available evidence is composed entirely of review articles, and no statistically significant individual study findings were reported. The most studied populations include individuals with cedar pollen allergy, atopic dermatitis, and allergic rhinitis, but specifics on dose, duration, and form were not consistently reported.

  • Studied populations: people with cedar pollen allergy, atopic dermatitis, allergic rhinitis

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests. Evidence base consists entirely of review articles with no primary RCT data providing explicit statistical significance, effect sizes, or dosing details, limiting confidence in the findings.

Generated Jun 11, 2026
11 of 11 papers
Back to top